SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: yosi s who wrote (701)5/3/1998 11:21:00 PM
From: InvestorLady  Read Replies (3) | Respond to of 1491
 
<<In view of activity on this thread Guess PARS will open much higher and will soon be
back to 3$.and will trade 3-4$ in second half of May.>>

Ah what activity would that be?

I don't see any stock going up during arbing until the arbing period is done which is determined by the terms of the warrants/convertible preferreds, and the arber's will, etc.

Technical support is at $2 5/16. Looking for that to hold sans any news.

Oh, and no offense intended...

:-)

Lady



To: yosi s who wrote (701)5/4/1998 5:09:00 PM
From: yosi s  Respond to of 1491
 
Well I guess PARS is to 2 31/32 3$ I guess with entremed all biotechs got a lift.
Lets see if PARS can maintain its upward trend.



To: yosi s who wrote (701)5/4/1998 5:24:00 PM
From: Stephen D. Wilson  Read Replies (1) | Respond to of 1491
 
yosi,

Excuse my ignorance but could you or someone else explain what the the word "cohort" means in relation to the testing process. I am unfamiliar with it..

Also, with the Phase II being done in Israel, will that increase the time frame of acquiring FDA approval (as opposed to the testing being done in the USA.

Thanks for all answers to help further my education in this field.

Steve